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A B S T R A C T
Background
Many people have asthma, and for some their symptoms may be triggered by psychological factors. In addition compliance with
medical therapy may have a psychological dimension. Therefore, psychological interventions aim to reduce the burden of symptoms
and improve management of the disease.
Objectives
To assess the effectiveness of psychological interventions for adults with asthma.
Search strategy
The Cochrane Airways Group specialised register and PsycINFO were searched with pre-defined terms until September 2003.
Selection criteria
Randomised controlled trials published in any language assessing the effects of a psychological intervention compared with a form of
control in adult participants were included in the review.
Data collection and analysis
Two reviewers assessed the relevance of abstracts identified by electronic searching and retrieved agreed studies for further scrutiny. The
studies that met the inclusion criteria were assembled and data extracted.
Main results
Twelve studies were included in the review, however study quality was poor and sample sizes were frequently small. No meta-analysis
could be performed due to the diversity of interventions and the outcomes assessed. Findings between studies were conflicting. This
may have been due to the different types of interventions used and the deficiencies in trial design.
Authors’ conclusions
This review was unable to draw firm conclusions for the role of psychological interventions in asthma due to the absence of an adequate
evidence base. Large, well-conducted and reported randomised trials are required in this area, in order to determine the effects of these
techniques in the treatment of asthma in adults.
S Y N O P S I S
There is not enough evidence to determine whether psychological interventions for adults with asthma help to improve symptoms and
mental health; more research is required.
It is thought by some that psychological interventions can help people with asthma. Systematically, we searched the literature on
psychological interventions to find valid studies that looked at the effects of providing mainly psychological interventions for adults
with asthma. The studies found examined many different therapies and measured different physical and psychological outcomes; for
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these reasons, their results could not be easily combined. Furthermore, the available studies were completed with small numbers of
people and the way the studies were conducted could be improved. More research with large numbers of people and improved design
needs to be done before it is known whether psychological interventions are effective in making adults with asthma feel better.
B A C K G R O U N D
Asthma is a condition, which is characterised by recurrent or
chronic variable airflow obstruction due to inflammation of the
airways resulting in airway smooth muscle contraction in response
to a number of chemical, physical and emotional stimuli. It is of-
ten divided into two types- allergic or extrinsic asthma and non-
allergic or intrinsic asthma. However, many asthmatics can have
symptoms from both allergic and non-allergic stimuli.
With few exceptions, there is no cure for asthma. Treatment is
aimed at controlling chronic and acute symptoms and maintain-
ing lung function to as near normal as possible. Modern treatment
methods rely on reducing airway inflammation and smooth mus-
cle contraction. Drugs are titrated according to symptoms, lung
function and side effects.
An estimated 5.1 million people in the UK have asthma (includ-
ing 1.4 million children). Asthma is expensive, resulting in an esti-
mated cost to the NHS in England of £850 million a year . There
are also indirect costs to the economy as over 18 million work-
ing days are lost due to the disease each year. People with asthma
also incur costs for medication, travel to GP surgeries and med-
ical equipment (NAC 2001). The high frequency of the disease,
and its attendant costs, have prompted the production of guide-
lines for the management of asthma (BTS 2003). These guidelines
include medication management as well as recommendations to
improve patients’ self-management skills in the form of Asthma
Action Plans. Most patients with asthma are treated in primary
care and outpatient settings and the overall success of treatment
relies on the contribution to effective management that the pa-
tient can bring to bear. This includes factors such as compliance
with medical therapy, effective inhaler technique and the ability
to manage psychological elements. Asthma has a psychological
component, including emotion (Lehrer 1993), so the treatment
of asthma increasingly needs to focus on the whole person, taking
account of psychological as well as physiological elements. This
means that evidence to support clinical staff in deciding upon the
type, format and frequency of psychological techniques is needed.
The aim of these strategies is to help reduce panic or fear, im-
prove breathing and respiratory function and impact positively on
general health and quality of life.
Literature is growing on the relationship between psychosocial fac-
tors and asthma. Bosley 1996 found in their review of studies on
asthma deaths and near fatal asthma attacks that asthma deaths are
related to lack of prompt medical treatment and lack of prompt ac-
tion by patients and their relatives. They also suggested that there
may be an association between psychiatric and asthma morbid-
ity and that a near fatal attack may increase denial or psychiatric
problems. Patient’s attitudes to their illness may affect their coping
skills and compliance with treatment. Because of the psychosocial
effects of asthma, strategies such as cognitive-behavioural therapy
(Kotses 1995), and group and individual counseling (Bailey 1990)
are now integrated with educational packages about the self-man-
agement of asthma in order to improve health outcomes. Other
psychotherapies that have been used are autogenic therapy (Henry
1993) and relaxation therapy (Lehrer 1994).
There is a growing body of work using review methodologies
to assess the impact of a range of psychosocial interventions in
asthma. For example, Devine 1996 showed that psychoeducational
programmes involving relaxation and behavioural techniques im-
proved health outcomes for adults with asthma. Reviews have been
undertaken on self-management education for asthmatic adults
(Gibson 2002a), limited asthma education for adults (Gibson
2002b) and family therapy for asthma in children (Panton 2002).
Gibson 2002a concluded that training in asthma self-manage-
ment, which involves self-monitoring by peak flow or symptoms,
coupled with regular medical review and a written plan, appears
to improve health outcomes for adults with asthma. Training pro-
grammes, which enable people to adjust their medication, also
appeared to be more effective than other forms of self-manage-
ment. In contrast limited asthma education, meaning information
only, did not appear to improve health outcomes in adults with
asthma, although perceived symptoms might improve (Gibson
2002b). Reviews led to the conclusion that more work is needed
to elucidate the effect of providing information in the emergency
department for adults (Gibson 2002b) and children (Haby 2002).
Panton 2002 in their review of the only two trials on family ther-
apy in asthma found some indication that this is a useful adjunct
to medication for children with asthma.
Khateeb 1995 suggested that psychotherapy appears to have a role
in the treatment of asthma. Hypnosis in asthma has also been the
subject of research over many years to assess its impact but it is
suggested that it is premature to conclude that hypnosis is un-
equivocally effective (Hackman 2000). With regard to relaxation
as a therapeutic technique in asthma, Ritz 2001 proposed that
more work was needed before a convincing case could be made.
A similar conclusion was reached in the latest systematic review of
relaxation therapies; there it was also suggested that there is limited
evidence to suggest that muscular relaxation may warrant further
investigation (Huntley 2002).
These reviews do not answer questions specifically about psycho-
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logical interventions and therefore a systematic review of the ef-
fectiveness of psychological interventions for adults with asthma is
also required. When managing patients, clinical staff need to have
reliable information on whether psychological techniques work,
and if so which are the most effective, for which patients. It is
also important to know whether interventions work best alone
or in combination with each other, and whether it is better that
patients are taught individually or in groups. If possible it would
also be useful for staff and patients to know what benefits may be
expected, and whether they are short-lived or last in the longer
term.
O B J E C T I V E S
The purpose of this study was to conduct a systematic review of
randomised controlled trials and a meta-analysis of all randomised
trials where the efficacy of psychological interventions in modify-
ing health and behavioural outcomes for adults with asthma was
investigated.
The specific objectives were:
1. To assess the overall efficacy of psychological interventions com-
pared with usual treatment in improving health and behavioural
outcomes for adults with asthma.
2. To assess the comparative efficacy of different types of psy-
chotherapy for adults with asthma.
3. To assess the comparative efficacy of individual and group for-
mats of psychotherapy for adults with asthma.
C R I T E R I A F O R C O N S I D E R I N G
S T U D I E S F O R T H I S R E V I E W
Types of studies
Randomised controlled trials (RCTs) comparing the effects of psy-
chological interventions for adults with asthma.
In the original protocol it was stated that this review would exam-
ine CCTs (case-controlled trials) on this subject as well, however
as RCTs provide the stronger level of evidence, it was decided to
concentrate on these only and a search strategy was designed to
include RCTs.
Types of participants
Adults, both male and female, over 16 years of age with asthma
who have been physician diagnosed or have been diagnosed using
internationally established criteria (e.g. BTS guidelines).
Treatments in both in and out patient settings were included.
Types of intervention
Any type of psychological intervention used in the treatment of
asthma in adults was considered for this review. Psychological
interventions have a long history and have been defined as the
procedure by which a therapist purposively and systematically at-
tempts to influence a patient by psychological means so that the
patients’ symptoms decrease or there is a positive change in be-
haviour (Barendregt 1957). These interventions will be delivered
by a trained practitioner or in consultation or supervision by a
trained practitioner.
Psychotherapy models were categorised according to their theo-
retical base as follows:
1. Cognitive behavioural therapy (incorporating core elements of
both behavioural and cognitive models)
Using behavioural techniques to change negative thoughts me-
diating health behaviour. In asthma, this may address incorrect
symptom attributions (over- or under-playing their significance)
giving rise to suboptimal medication use, or may use systematic
relaxation techniques to extinguish fear responses associated with
psychosocial triggers.
2. Cognitive therapy
Identification and constructive management of damaging
thoughts, such as perceptions of helplessness or inappropriate fear
of asthma attack that can trigger episodes. Information (e.g. about
the relationship between anxiety and bronchoconstriction) also
targets cognitions.
3. Behavioural therapy
Concerned with identifying the processes by which behaviour has
been learned via association, reward or observation and modifying
behaviour using methods such as systematic desensitization, selec-
tive reinforcement and positive modelling. The behaviour itself,
rather than underlying motivations, is the focus of behavioural
interventions.
4. Relaxation therapy with or without biofeedback
Designed to control stress & anxiety. In asthma, may reduce panic
or fear & improve breathing and respiratory function. Approaches
include progressive relaxation (systematically creating tension and
release in different parts of the body and/or via guided mental
imagery), autogenic training (focuses on attending to bodily feel-
ings and mentally controlling them), hypnosis (deep relaxation
that may be induced using mental imagery, often accompanied
by autosuggestion to create positive thoughts & feelings), and
biofeedback (feedback of biological indicators), which the subject
must control via relaxation. May also be considered a behavioural
intervention since the feedback can act as a reinforcer.
5. ’Supportive’ counselling
Counselling involves talking over problems with a health profes-
sional. In supportive counselling, the counsellor simply aims to be
a good listener and provide emotional support, rather than offer-
ing a more targeted psychotherapeutic intervention. It generally
focuses on problems in the here and now and has a short-term
duration.
6. Hypnosis
Conceptualizations of hypnosis vary. At the broadest it can be
regarded as a form of deep relaxation induced by guided mental
imagery. In this sense it may be placed with other types of relaxation
therapy. Hypnosis is also thought to induce a state of suggestibility,
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facilitating both patients’ insight into their unconscious motives
or anxieties and the absorption of therapeutic messages.
7. Individual and group format
Some therapies can be delivered to groups of individuals as well as
single patients. Social interaction within a supportive non-judg-
mental peer group may increase self-esteem and encourage dis-
closure, both of which may (under appropriate circumstances)
facilitate therapy.
Patient education programmes were only included where psy-
chotherapy formed the major part of the intervention. Breath-
ing retraining, yoga and massage therapies were not included in
this review as these therapies were not considered to be primarily
psychological in nature.
Types of outcome measures
The types of outcome measures that might be expected are:
1. Level of severity of asthma symptoms
2. Medication usage
3. Lung function (e.g. Peak expiratory flow (PEF), forced volume
capacity (FVC), spirometry)
4. Immune function
5. Health service utilisation (e.g. hospitalisation, GP visits)
6. Asthma knowledge questionnaires
7. Psychological questionnaires (e.g. coping skills, anxiety, asthma
related behaviour scales, locus of control, self esteem, quality of
life, psychological status)
8. Change of behaviour scales
9. Absenteeism from school or work
For the purposes of the review the primary outcomes include phys-
ical and psychological outcomes, namely:
1. Frequency, severity and duration of asthma symptoms
Although these encompass three measures of asthma symptoms,
the diversity with which these outcomes were recorded prompted
us to group these together.
2. Psychological health status (e.g. anxiety, locus of control, self-
esteem and quality of life) These encompass several measures of
psychological well-being, but again, there was much diversity in
the reporting of these outcomes, hence they are pooled as a group.
The secondary outcomes are:
1. Treatment: e.g. doses of reliever per time period, daily dose of
inhaled corticosteroid
2. Health service utilisation: e.g. A&E visits, hospitalisation, GP
visits
3. Absenteeism from work or school
4. Lung function
5. Markers of inflammation
6. Patient satisfaction.
S E A R C H S T R A T E G Y F O R
I D E N T I F I C A T I O N O F S T U D I E S
See: Airways Group search strategy
The Cochrane airways group register of controlled trials was
used to identify randomised controlled trials, see Airways Group
search strategy. The register includes references from MEDLINE,
EMBASE, CINAHL, hand searched respiratory journals,
meeting abstracts, and from searching the bibliographies of all
trials. The Airways Asthma database was searched using the
following terms:
Psychotherap* or group Psychotherap*
An advanced search of the CENTRAL Cochrane Controlled
Trials Register (CCTR) was also completed using the above
search strategy. A search for relevant trials used the search terms
asthm$ or wheez$ and the exploded term Psychotherapy.
An extensive search was also made of the electronic register
PsycINFO using the following search strategy-
Asthm$ OR Wheez$ AND psychotherap$ OR psychol$
Bibliographies of each identified trial were also searched for
additional papers that might contain relevant trials.
Searches were updated annually; studies found up to the end of
September 2003 were included.
Authors of all studies included in the review were contacted and
asked to identify further published or unpublished work. In
addition researchers known by the reviewers to have conducted
a relevant study and to know the subject of the review were
approached to identify other possible studies.
M E T H O D S O F T H E R E V I E W
Study selection
The literature search identified eighty-five possibly relevant
studies. Two independent reviewers (SF & CS) established
whether each study met the inclusion criteria as an RCT of
a psychological intervention for adults with asthma according
to the above inclusion criteria. Disagreements were resolved by
discussion. Twelve RCTs were appropriate for inclusion in this
review (see Included Studies table).
Methodological quality
The methodological quality of the studies (allocation concealment)
was independently assessed by two reviewers (SF & CS) using the
following criteria for allocation concealment:
Grade A: adequate concealment
Grade B: uncertain
Grade C: clearly inadequate concealment
Grade D: not used
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There were no disagreements on ratings given to studies.
Each study was also assessed using a modified 0 to 5 scale developed
by Jadad 1996 and summarised as follows:
1. Was the study described as randomised (1=yes;0=no)?
2. Was the outcome assessment blinded (1=yes;0=no)?
3. Was there a description of withdrawals and dropouts
(1=yes;0=no)?
4. Was the method of randomisation well described and
appropriate (1=yes;0=no)?
5. Was the method of blinding well described and appropriate(1=yes;0=no)?
6. Deduct one point if methods for randomisation or blinding
were inappropriate.
Modification of this scale was essential as, due to the nature of
the psychological interventions, it would be difficult to conduct
double-blinded trials. Therefore in step 2 and 5 ’double-blind’ has
been changed to ’blind’.
There was one disagreement on assessments between reviewers (SF
& CS) and this was resolved by discussion.
The methodological quality of the studies was poor with only two
studies rated Grade A (adequate) for allocation concealment (Ewer
1986; Mussell 1988), the remainder being rated Grade B, C or D.
One RCT (Put 2003) had a rating of 4 on the Jadad scale, two had
a rating of 3 (Ewer 1986; Loew 2001) with the remainder scored 2
or 1. Where allocation concealment or the randomisation process
was unclear, letters were sent to authors asking for this information.
However, as most of these studies were completed some time ago,
correspondence from only two authors (Ewer 1986; Sommaruga
1995) was received (apart from information that authors had died
or moved away).
Data analysis
Data from the twelve RCTs could not be entered into RevMan
4.1 for statistical analysis for the following reasons-
The studies were assessing different psychological interventions
and even though several used relaxation therapy, the interventions
were so diverse, it was not possible to pool results. Also, the studies
either used different outcomes to measure the effectiveness of the
intervention, or if the same outcomes were used- the data was
presented in a method that could not be used (e.g. in graphical
form). Authors were contacted to ask for data from these studies
but this met with no response.
Therefore, outcome data could not be combined by meta-analysis
in this review but are discussed descriptively. Where means and
standard deviations were reported, 95% confidence intervals of
the mean difference were calculated by an author (SF).
D E S C R I P T I O N O F S T U D I E S
Study Design
See Included Studies table. Twelve studies were included in the
review, with two publications from one study reporting different
outcomes (Henry 1993). All were randomised and were conducted
over a variety of durations (3 days to 12 months). Ten studies (De-
ter 1983; Erskine 1979; Ewer 1986; Henry 1993; Lehrer 1994;
Lehrer 1997; Payette 1977; Put 2003; Sommaruga 1995; Waga-
man 2000) were of parallel design and two (Loew 2001; Mussell
1988) were of cross-over design.
Interventions used
The types of intervention were also diverse. Eight studies used
some form of relaxation technique as their intervention (De-
ter 1983; Erskine 1979; Ewer 1986; Henry 1993; Lehrer 1994;
Lehrer 1997; Loew 2001; Payette 1977) however techniques used
ranged from autogenic therapy to hypnosis and progressive mus-
cle relaxation. Different placebo formats or different therapies
were also used as controls. The other three studies used tracheal
noise biofeedback (Mussell 1988), cognitive behavioural therapy
combined with rehabilitation (Sommaruga 1995) a psycho-ed-
ucational programme which included behavioural and cognitive
techniques (Put 2003) and hypnotic suggestions to improve im-
mune function and symptom relief (Wagaman 2000). Details of
the interventions used are described in the included studies table.
It should be pointed out that single methods are seldom used
and most practicing therapists use an eclectic approach employing
different combinations of therapies to suit the individual circum-
stances (e.g. presumed mechanism of influence, patient charac-
teristics, therapist preferences). There is also considerable overlap
between methods; for example, relaxation techniques are part of
the armoury of tools used for behaviour modification. In asthma,
all of these techniques are used in combination with drug thera-
pies.
M E T H O D O L O G I C A L Q U A L I T Y
Overall the methodological quality of the studies was poor, with
several weaknesses in experimental design. Jadad scores varied be-
tween 1 and 4 with only one study rated at 4 (Put 2003) and
two studies rated at 3 (Ewer 1986; Loew 2001). The studies by
Erskine 1979, Lehrer 1994, Mussell 1988; Sommaruga 1995 and
Wagaman 2000 were accorded 2 points while the rest (Deter 1983;
Henry 1993; Lehrer 1997; Payette 1977) received 1 point.
Only two studies rated Grade A (adequate) for allocation conceal-
ment (Ewer 1986; Mussell 1988) the remainder being rated Grade
B (unclear) (Deter 1983; Erskine 1979; Henry 1993; Lehrer 1994;
Loew 2001; Put 2003; Sommaruga 1995); Grade C (inadequate)
(Wagaman 2000) or D (not used) (Lehrer 1997; Payette 1977).
Study Participants
The studies were generally small with only one having more than
a hundred people included (Lehrer 1994 recruited 106 people).
The smallest (Erskine 1979) had 12 and the largest of the rest
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(Sommaruga 1995) 40 people. A power calculation to determine
sample size was only done in one study (Lehrer 1994). Four studies
included details about how many people were approached to join
the research: Deter 1983 where 90 people were invited and 27
declined to join and 34 agreed (no information is given about
the other 29 people), Lehrer 1994 where 47 more people were
screened than actually participated in the study. Put 2003 invited
101 and 25 agreed and Wagaman 2000 where 90 people attended
an initial interview resulting in 30 joining the research. No further
data are provided from the other studies.
In some studies a description of withdrawals was not given (Henry
1993; Mussell 1988; Payette 1977; Sommaruga 1995). Erskine
1979; Ewer 1986; Lehrer 1997 and Wagaman 2000 gave the num-
bers who withdrew but no details of their characteristics. Deter
1983 did not mention withdrawals but eleven people appear not
to have completed the study and it is difficult to see what happened
to patients, as the numbers do not tally. Lehrer 1994 referred to
patients who had dropped out, but also seemed to have a group
who completed the treatment but for whom there are no measure-
ments. Loew 2001 excluded patients (n = five) from some of the
measures when they did not experience bronchoconstriction. Al-
though Put 2003 commented on missing data there was no other
discussion about missing data and the potential impact this might
have had on the findings. In no study was there a clear plan en-
abling the reader to track easily the progress of patients approached
or included in the trial and there was no discussion about missing
data and the potential impact this might have had on the findings.
The severity of asthma varied from mild to severe, however not
all studies reported this. Participants with co-morbidity were ex-
cluded from the studies.
Method of randomisation
Studies were randomised with patients allocated to control and
experimental groups, however authors tended not to be clear as to
whether all the patients who were eligible for the study were ap-
proached. Frequently the method of randomisation was not men-
tioned (Deter 1983; Erskine 1979; Henry 1993; Lehrer 1994;
Lehrer 1997; Mussell 1988; Payette 1977; Wagaman 2000). Put
2003 had a system of drawing from unmarked envelopes. Loew
2001 used a computerised randomisation scheme to determine the
sequence of the tests. Ewer 1986 reported that the outpatient de-
partment sister, who had no other involvement in the study, was
responsible for the randomisation and on correspondence con-
firmed randomisation was done by computer. Sommaruga 1995
also confirmed on correspondence that randomisation was done
by computer. Therefore it is difficult in all the studies to gauge
whether the method of randomisation was appropriate. This is
reflected in the Jadad scores.
Sometimes a researcher blinded to the participants group assessed
the outcomes. Put 2003 used independent researchers who were
unaware of the patient’s treatment allocation. Ewer 1986 involved
the outpatient department sister who was blind to the patient’s
group and although the author conducted the intervention, they
are clear that the challenge test was conducted with a researcher
who was blinded. Mussell 1988 used placebo treatments and re-
ferred to the study being double blind as to the treatment or-
der. Loew 2001 refer to their study as being single-blind but are
not clear whether the researcher or the subject was blinded. As
they used a placebo relaxation technique, the subjects may have
been blinded to the active treatment. Assessment of outcome in
Payette 1977 was not blinded and in Lehrer 1997, the same person
undertook the treatment intervention and measurement. Waga-
man 2000 stated that assessments and medical assessments were
blinded, but the investigator performed the interventions and de-
livered the psychometric assessments. All other authors failed to
mention whether the assessment of outcomes was blinded or not.
In general therefore, the conclusion reached about the quality of
the studies reflects the comment made by Ritz 2001:653, in his
overlapping systematic review, that ’most of the few available stud-
ies suffer from inadequacies in experimental design, instrumenta-
tion, procedures and/or reporting of results’.
Outcomes
A wide variety of outcomes were used. These included objective
measures of lung function such as FEV1, FVC and peak flow (Er-
skine 1979; Ewer 1986; Henry 1993; Lehrer 1994; Lehrer 1997;
Loew 2001; Mussell 1988; Payette 1977; Put 2003; Wagaman
2000) or medication usage (Deter 1983). Asthma symptoms were
measured (Erskine 1979; Ewer 1986; Lehrer 1994; Lehrer 1997;
Put 2003; Sommaruga 1995; Wagaman 2000). In contrast some
researchers measured psychological traits such as anxiety (Deter
1983; Ewer 1986; Sommaruga 1995; Wagaman 2000), fear (De-
ter 1983) or health locus of control (Sommaruga 1995). Health
service utilisation was measured by Deter 1983; Sommaruga 1995
and Wagaman 2000.
R E S U L T S
Primary outcomes
Frequency, severity and duration of asthma symptoms
This was measured by seven studies (Erskine 1979; Ewer 1986;
Lehrer 1994; Lehrer 1997; Put 2003; Sommaruga 1995; Waga-
man 2000). Put 2003 used the McMaster Asthma Quality of Life
Questionnaire (Juniper 1992) and the Asthma Symptom Check-
list (Kinsman 1973). Measurements were taken at baseline for both
groups. For the experimental group they were taken again immedi-
ately after the intervention (which lasted three months) and three
months thereafter. The waiting list controls had measurements at
three and six months after baseline. There were significant differ-
ences in symptoms (p< 0.05) between groups. Analysis of variance
showed differences in obstruction (F (2,42)=3.3, p< 0.05), fatigue
(F(2,42=7.9,p=0.001) and irritation (F(2,42)=3.8, p< 0.05), with
6Psychotherapeutic interventions for adults with asthma (Review)
Copyright ©2005 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd
the treatment group reporting a decrease in symptoms. There were
no significant differences for dyspnoea and hyperventilation.
The findings for the between group analyses for the rest of the
studies were not significant, however some significant results were
found on within or whole group analysis.
One study (Sommaruga 1995) of an asthma rehabilitation pro-
gramme including cognitive behavioural therapy resulted in both
the intervention group and the control group having less asthma
attacks (data to support this are not provided, apart from p<0.05).
Nocturnal symptoms i.e. sleep, and wheeze, activity, cough and
phlegm were reported in one study (Ewer 1986). They examined
the impact of hypnosis on people with a history of mild to mod-
erate asthma. Patients were separated as to whether they scored
high or low on a scale to measure their susceptibility to hypno-
sis (Stanford hypnotic clinical scale). Daily symptom scores, the
rating scale is not given, were averaged for the first two and the
last two weeks of the treatment period. In the high susceptibil-
ity group who received the hypnosis intervention, the subjective
scores for nocturnal symptoms, wheeze and activity limitations
improved after treatment. Mean percentage change in symptom
scores was -62 (p <0.05) for sleep, -53 (p<0.001) for wheeze and
-58 (p<0.01) for activity. No significant change was found in either
the low susceptibility treatment or control groups.
Bronchoconstriction, hyperventilation, panic-fear, irritability and
fatigue were measured in a study by Lehrer 1997. Within group
differences, before and after treatment, were not significant for
bronchoconstriction and hyperventilation and no differences were
found for the other three outcomes. Between group differences
were not reported and it is assumed that these were not significant.
Hyperventilation severity (F=3.97, df=2,106, p<0.04) and fre-
quency (F=4.82, df=2,106, p<0.02) using an asthma symptom
checklist (Lehrer 1994) showed within group differences over the
course of treatment with relaxation and music therapies but there
was no significant differences between groups.
Subjective symptoms before and after hypnosis sessions were mea-
sured by Wagaman 2000 using the Asthma Symptom Checklist
(Kinsman 1973). The groups were too small to allow statistical
analysis to test for differences, however the whole sample had a
decrease in overall symptoms post intervention when compared to
pre-intervention measurement, however no usable data were pre-
sented. Frequency of acute attacks as measured by patient diaries
were unable to be assessed statistically due to the small sample and
the infrequency of these attacks.
Psychological Health Status- Anxiety, Locus of Control, Self-es-
teem, Quality of Life
Anxiety was used as an outcome measure in five studies (Deter
1983; Ewer 1986; Put 2003; Sommaruga 1995; Wagaman 2000).
Health locus of control was examined in Sommaruga 1995 and
psychological symptoms in one (Erskine 1979). Anxiety was mea-
sured using the State-trait Anxiety Inventory (Spielberger 1970)
in Ewer 1986- but no data are presented. There were no signif-
icant differences between groups for psychological health status,
but there were some within group differences.
Trait anxiety was measured by Sommaruga 1995. Patients were
treated in an Asthma Rehabilitation Group involving education
and a cognitive behavioural intervention. There were significant
differences between baseline and one year follow up in those who
received the intervention, in respect of trait anxiety (data at enrol-
ment (t0) showed a mean 43.2 (SD10.0) and at 1 year (t1) 36.7
(9.1),p<0.0005), psychophysiological disorder (t0 48.7 (9.3) t1
45.1 (9.4), p<0.02) and depressive symptoms (t0 5.8 (3.7) t1 3.6
(3.0), p<0.006), but not for psychophysiological disorder in the
control group. There are other outcomes studying optimism, nega-
tive staff regard, internal awareness, external control, psychological
stigma and authoritarian attitude from a Respiratory Illness Ques-
tionnaire (Staudenmayer 1978). Within group analyses showed
significant decreases for external control (data at enrolment (t0)
showed a mean 10.1 (SD3.8) and at 1 year (t1) 8.4 (3.5),p<0.05)
and psychological stigma (t0 9.0 (3.8), t17.5 (3.8),p<0.03) in the
intervention group and psychological stigma (t0 10.2(5.6) t17.8
(3.8) p<0.03) in the control group.
Anxiety, using the MMPI (Minnesota Multiphasic Personality In-
ventory) showed an increase for the intervention as compared to
the control group which is referred to as ’a tendency to react posi-
tively’ although the implication of a higher score may be of worse
anxiety. The magnitude was small with an increase or decrease of
one point only, which is unlikely to have either clinical or statisti-
cal significance (Deter 1983). Anxiety is a sub-scale on the asthma
symptom checklist used by Put 2003. No significant differences
between groups were found.
State anxiety was assessed in Wagaman 2000. The groups were
too small to allow statistical analysis to test for differences between
the two intervention groups and the control group, however the
whole sample had a significant decrease in anxiety post interven-
tion (at one year follow up) when compared to pre-intervention
measurement (mean change -12.09; t=4.13;p<0.01). The same
study assessed neuroticism, extraversion and lying (Eysenck Per-
sonality Inventory), repressive coping (Marlowe Crowne Social
Desirability Scale (Crowne 1960)), self-control methods to the
solution of behavioural problems (Self-Control Schedule (Rosen-
baum 1980)), and catastrophising
(Dysfunctional Cognition Inventory (Zocco 1985)). There were
no significant differences found.
Health locus of control, including internal beliefs, and external
control through powerful others and chance was measured using
the Health Locus of Control Scale (Wallston 1976) in an Italian
version in a study by Sommaruga 1995. There were no significant
differences between baseline and one year follow-up except an
increase in beliefs about ’external chance’ in the control group.
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’External chance’ on the Health Locus of Control Scale measures
the belief that health depends on casual factors and luck (t0 9.9
(3.5) t1 11.5(3.0) p<0.03).
Panic/fear and fatigue using an asthma symptom checklist (Lehrer
1994) showed differences over the course of treatment with relax-
ation and music therapies in an RCT. They report no significant
differences between groups, but panic/fear severity did decrease for
the whole sample (F=3.34, df =2,104, p<0.02). Wagaman 2000
also included panic/fear and fatigue but did not present usable
data.
Psychological symptoms were examined in a RCT of relaxation
therapy, using a self-report weekly symptom questionnaire incor-
porating a five-point severity rating scale (Erskine 1979). Data
showed no difference between the two groups (muscular relax-
ation, and mental and muscular relaxation) and patients overall
did not show any significant reduction in symptoms and signs.
Psychological elements were examined in a trial of autogenic ther-
apy (Henry 1993) with measures of the patient’s state- ’vegetative’,
emotional, behavioural, cognitive and reactivity to stress with no
significant differences between baseline and follow up in either
group, with the exception of ’vegetative’ state in the experimen-
tal group (mean difference (SD) 1.83(2.69) p<0.05). A Negative
Emotionality Scale, which incorporates measures of negative af-
fectivity as a personality trait, including irritability, nervousness
and emotional instability was used by Put 2003. People in the
experimental group had a decrease in scores, suggesting improve-
ment, and there were significant differences between experimental
and control groups (F(2,42)=10.8,p=0.0002).
Temperament was studied in Payette 1977 using the Taylor-John-
son Temperament Analysis (Taylor 1974) with no significant dif-
ferences found between a group receiving biofeedback training
and a control group.
Lehrer 1994 included measures of the most relaxed and tense
moment in a session using a 9-point Likert scale. They found
a significant treatment effect for relaxation during the training
session, with the waiting list group being less relaxed (mean 4.2
(SD 1.5)) than the progressive relaxation groups (2.8 (1.4)) during
their eighth session (p<0.05, 95% CI 0.6 to 2.2).
Henry 1993 found no significant differences between groups when
measuring reactivity to stress. Reactivity to stress is the extent to
which the body reacts to stressors. It can be assessed by comparing
physiological measures in a resting state (baseline or relaxation)
to those in the presence of a physical or psychological stressor.
Psychological outcome measures may also be used.
Secondary Outcomes
Treatment
Four studies examined intervention effects on treatment (Deter
1983; Ewer 1986; Lehrer 1997; Wagaman 2000). Each trial used
a different method of measuring this outcome so effects could not
be pooled. Deter 1983 found a significant difference in the num-
bers of people in the experimental group (n=4) who required less
bronchodilators when compared to the control (n=0; p<0.05).
For the sub-group of people with a high susceptibility to hyp-
nosis, Ewer 1986 found the treatment group had significantly less
bronchodilator use after treatment (mean 34.0 puffs/day (SD7.8))
when compared to before treatment (46.0 (7.2), p<0.05). Lehrer
1997 found no significant differences when measuring amounts of
inhaled or oral steroids taken at 6 weeks post intervention. Waga-
man 2000 found significant decreases in medication requirements
in both of the experimental groups and a significant increase in the
control group at one year after hypnotic suggestions were given.
No usable data was presented to demonstrate this.
Health Service Utilisation
Three studies (Deter 1983; Sommaruga 1995; Wagaman 2000)
examined this outcome and there were no significant differences
between experimental and control groups. Each study measured
this outcome using different methods so data could not be pooled.
Sommaruga 1995 found numbers of hospitalisation days and
number of emergency visits were decreased for both the interven-
tion group (an asthma rehabilitation programme) and the control
group (data to support this are not provided, apart from p<0.05).
Numbers were too small in the Wagaman 2000 study on hypnosis
to test for statistical differences for this outcome.
Absenteeism from work or school
Two studies examined this outcome by using patient diaries (Waga-
man 2000) and recording the number of work/school absences
(Sommaruga 1995). Work/school absences were significantly de-
creased post-intervention for both the asthma rehabilitation group
and the control group (data to support this are not provided, apart
from p<0.05). Numbers were too small in each group to test for
statistical differences in the Wagaman 2000 study.
Lung Function
Eleven RCTs (Deter 1983; Erskine 1979; Ewer 1986; Henry 1993;
Lehrer 1994; Lehrer 1997; Loew 2001; Mussell 1988; Payette
1977; Put 2003; Wagaman 2000) used lung function as an out-
come to measure the effectiveness of their intervention. Of these,
two used a hypnotic technique to relax subjects (Ewer 1986) and to
improve immune function (Wagaman 2000), seven trials used re-
laxation therapy (Deter 1983; Erskine 1979; Henry 1993; Lehrer
1994; Loew 2001) two including biofeedback training (Lehrer
1997; Payette 1977), and another used tracheal noise biofeedback
training to reduce bronchoconstriction (Mussell 1988). The final
one (Put 2003) used a psychoeducational intervention, which in-
cluded behavioural and cognitive techniques. Data could not be
pooled in Metaview as the interventions used were too diverse.
Data could not be pooled in Metaview as the interventions used
were too diverse. In some studies, data was often presented in a
format that could not be analysed (e.g. graphically). There was no
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response from authors of these studies on written request for raw
data.
Methacholine challenge test.
A methacholine challenge test to detect improvement of asthma
following intervention was used in two RCTs. One adopted a hyp-
notic technique to relax subjects (Ewer 1986) and the other study
used relaxation training (Lehrer 1994). No significant treatment
effects were shown in the RCT using relaxation training. In the
trial using a hypnotic technique the most important finding was
a significant improvement in bronchial hyper-responsiveness for
patients with a high susceptibility for hypnosis. The data using
mean PC20 (SEM) were 9.09 (1.71) before treatment and 15.9
(2.79) after treatment (P=0.008), where PC20 is the provocation
concentration of methacholine that caused a 20% fall in FEV1.
Spirometry
Spirometry was used in nine RCTs, however only three studies
used the full range of spirometric tests as outcomes (Ewer 1986;
Henry 1993; Lehrer 1994). Two RCTs, one using relaxation and
the other biofeedback training (Erskine 1979; Mussell 1988) used
FEV1 (forced expiratory volume in one second) only. Another,
(Put 2003), measured Peak Expiratory Flow Rate (PEFR). Sig-
nificant differences were found for day (F(2,40)=3.8,p=0.02) and
night (F(2,40)=3.3, p<0.05) PEFR with the experimental patients
faring best. The remaining three studies used a variety of measures
(Loew 2001; Payette 1977; Wagaman 2000). There were no signif-
icant differences between groups for spirometry measures, however
there were some within group improvements.
Ewer 1986 found significant improvement in FVC (forced vi-
tal capacity) for both intervention (6.9%) and control groups
(5.03%) p< 0.002, PEF (peak expiratory flow) and MEF (mid
expiratory flow) (50%) for the treatment group after hypnosis of
11.7% (p<0.002) and 14.7% (p<0.05) respectively when com-
pared to baseline measurements. Henry 1993 found significant
improvements in spirometric measures for the treatment group af-
ter autogenic therapy when compared to baseline measurements.
These were- FVC (mean difference 0.31 (SD 0.24) p<0.001, % of
predicted value of FVC (14.3 (8.39) p<0.001, FEV1 (0.35 (0.36)
p<0.01), % of predicted value of FEV1 (16.3 (12.4) p<0.001),
FEF25-75 (middle half of forced expiratory flow) (0.44 (0.58)
p<0.5), % of predicted value of FEF25-75 (12.1 (15.5) p<0.05)
and % of predicted value for MEF50 (13.6 (19.9), p<0.05).
Lehrer 1994 found no significant differences between groups for
any of the spirometry measures after relaxation therapy. How-
ever significant decreases pre-test to post-test occurred for a sub-
group of people (37) from the whole sample for PEF [F(1,49) =
8.12, p<0.007] and FEF50 [F(1,49) = 12.29, p<0.001]. Signifi-
cant pre-test to post decreases also occurred for the whole sample
for FEV1 [F(1,87) =21.56, p<0.001] and FEV1/FVC [F(1,87) =
13.64, p<0.0005]. Loew 2001 showed significant improvement
for the functional relaxation group for FEV1 (mean difference of
%values -1 (SD 7), p<0.05), PEF (-1 (14), p<0.05), MEF50 (0
(10), p<0.01) and MEF75 (-3 (10), p<0.01) when compared to
baseline measures. Payette 1977 found no significant differences
between groups for FVC, FEV1, FEV1/FVC (ratio of FEV1 and
FVC) after EMG biofeedback training. Wagaman 2000 also found
no significant differences between groups for FEV1, FEF 25-75,
and PEF after hypnotic suggestion. Erskine 1979 and Mussell
1988 also reported no significant differences between groups for
FEV1 measurements.
Airways resistance
Airways resistance was measured in three RCTs (Deter 1983;
Lehrer 1997; Loew 2001). There was no significant difference be-
tween groups for airways resistance, however Lehrer 1997 showed
significantly decreased airways resistance for the RSA biofeedback
group (F(4,21) + 2.91, p<0.05) compared to pre-test measures.
Loew 2001 also showed significant improvement for the func-
tional relaxation group for airways resistance (Mean difference pre
to post treatment 38% (SD 63) p<0.01) and specific airways resis-
tance (Mean difference pre to post treatment 53% (SD 85) p<0.01)
when compared to baseline measures. There were no significant
differences for the control group. Data was presented for airways
resistance (Mean 4.78 (SD 3.22)) and conductance (0.083 (0.48))
for the intervention group only in Deter 1983 with no significant
differences found.
Markers of Inflammation
Immunoglobulins (IgE, IgA, IgM, IgG) were measured in Deter
1983 and showed that 82% (n=19) of patients had a raised 1gE,
8% (n=2) raised 1gM values and 4% (n=1) raised 1gE. There was
much missing data and immunoglobulins were not used as an
outcome measure.
Patient Satisfaction
Patient satisfaction with the intervention, and a report on its effec-
tiveness, were mentioned by Lehrer 1994 but no data are presented
and no further comment was made about these measures.
D I S C U S S I O N
This systematic review evaluated twelve trials of varied psycholog-
ical interventions for adults with asthma and found that generally
these interventions do not decrease frequency, severity and dura-
tion of asthma symptoms or decrease health service utilisation.
However, there were some positive effects found in some stud-
ies. Put 2003, describing one of the better designed trials, showed
significant differences between experimental and control patients
on a range of outcomes. These include symptoms such as ob-
struction, fatigue and irritation, as well as an aspect of lung func-
tion and psychological state. Another trial (Deter 1983) evaluating
autogenic therapy found a significant decrease in the amount of
bronchodilators taken for the intervention group, however another
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three trials which tested different interventions but evaluated this
outcome reported no significant differences (Ewer 1986; Lehrer
1997; Wagaman 2000). Lehrer 1994 found that progressive relax-
ation resulted in the intervention group being significantly more
relaxed, but no further significant differences were found between
groups for psychological health status. With the exception of Put
2003, there were no significant differences in lung function be-
tween intervention and control groups for any of the interventions
but there were some within group improvements. However, these
improvements should be viewed with caution as the within group
outcomes reported are not covered by the randomisation process
and are reported in this review for comprehensiveness only.
Trials evaluating hypnosis (Ewer 1986), autogenic therapy (Henry
1993) and functional relaxation (Loew 2001) found lung function
improved for the intervention group from baseline measurement
to post-intervention measures. However a trial of progressive mus-
cle relaxation (Lehrer 1994) found significant decreases in lung
function for the intervention group from pre to post-session mea-
sures. Improvement of airways resistance was found for the inter-
vention group after a trial of functional relaxation therapy (Loew
2001) and another trial evaluating biofeedback training (Lehrer
1997).
There is a general view that asthma is connected with psycho-
logical elements in the person (Lehrer 1993). This may involve a
cause and effect relationship and because psychology and emotion
are involved it is thought that psychological techniques may have
a positive effect on patient outcomes. Psychological techniques
may be effective in improving patients asthma symptoms, how-
ever there is no suggestion that these techniques could act on their
own, rather as a supplement to medical treatment. There is a large
worldwide literature base supporting these ideas but this review
shows that questions of effectiveness have not yet been answered.
It is clearly a difficult area to investigate and presents challenges
for the design of good RCTs. Researchers have to recruit sufficient
numbers of subjects to show an effect if there is one, ensure ap-
propriate randomisation and blinding techniques and follow up
subjects for a reasonable period.
RCTs evaluating this area are diverse. They study a mixed group of
psychological techniques, which are difficult to classify due to the
different methods used to deliver the intervention. This resulted in
heterogeneous interventions even when the technique was given
the same classification by study authors. It was then impossible to
analyse any of these interventions collectively.
The diversity of the interventions was also complicated by a mul-
tiplicity of outcomes and the tools used to measure these. There
is no consensus on which outcomes a psychological intervention
might influence and the conceptual link between them. The most
common outcome used in the studies reviewed was lung func-
tion; eleven of the studies evaluated this. However, whilst lung
function was widely assessed, different measurements were taken,
for example % predicted FEV1 and PEF L/min. Health care util-
isation is increasingly being used as a primary outcome in drug
trials and other studies on patients with asthma. This being the
case, the primary outcome of this review may need to change as
being hospitalised or being ill enough to visit the GP may be the
most important outcome for the patient, however few trials in-
cluded in this review have used this outcome. It is assumed that
self-report measures were used, and these may not give accurate
data.
The psychological outcomes used were even more numerous and
diverse and there seems to be no consensus as to which psycho-
logical outcomes are conceptually linked to asthma or to the psy-
chological interventions being studied.
An added complication was that two of the studies (Loew 2001;
Mussell 1988) used a cross over design. This may not be an ap-
propriate design to evaluate psychological interventions, as the
influence of a treatment might continue after the intervention has
been stopped. No account was taken for this potential carry-over
effect in the analyses. This should be considered in the design of
future studies.
It is apparent that this body of work does not seem to have a clear
direction where current work is influenced by previous studies.
Most of these small studies were done by trialists who, with the
exception of Lehrer’s team, did only one study. This has resulted in
diverse studies looking at diverse interventions reporting on large
numbers of different outcomes.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
Because of the poor methodological quality and small sample sizes
of the trials included, this review can draw no conclusions as to the
effectiveness of psychological techniques for adults with asthma.
The results from current RCTs in the field do not allow us to
answer any of our original objectives. This review cannot therefore
provide guidance for clinical practice.
Implications for research
Larger RCTs with good methodological quality are needed. There
are a limited number of rigorous trials in this area and comparisons
are frustrated by diversity of outcomes and poor results reporting.
All pertinent results such as means and standard deviations should
be reported to aid comparisons.
As asthma is a complex multi-factorial illness, the inclusion crite-
ria used to select patients for research is important. Interventions
should be targeted at groups of patients who are most likely to
benefit from them, not broadly for ’patients with a confirmed di-
agnosis of asthma’ as most RCTs have done in this review. For
example, cognitive behavioural therapy to reduce emotional ex-
acerbation of asthma will not be effective if the patient is not
suffering acute stress or anxiety due to their asthma. This was
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addressed by only one study, Put 2003 where only participants
with ’reported asthma symptomatology and impairment despite
adequate medical treatment’ were recruited.
There does not seem to be a developed programme of research
for evaluating psychological interventions for adults with asthma,
with many research teams doing just one study. Researchers in the
field should agree common interventions, taxonomy and outcome
indicators. There is a question over how appropriate it is to conduct
RCTs of psychological interventions at all. This mainly has to do
with the fact that, in practice, isolated therapies are seldom used
and treatment plans are individualised to patients as complex self
-management plans.
Evaluation using an RCT in the clinical setting may mean that
the intervention is so tightly controlled that even if effectiveness
were proven it might be difficult to transfer the intervention into
routine clinical practice. Research funding should target a range
of good quality research, including well designed rigorous RCTs,
to determine the effectiveness and cost effectiveness of psycholog-
ical techniques that have a sound theoretical base, with common
taxonomy and outcome indicators and which can be used in the
real world with individual patients who have differing needs and
get better at different speeds.
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T A B L E S
Characteristics of included studies
Study Deter 1983
Methods RCT (parallel design).
Method of randomisation: randomised into 3 groups, method not described.
Outcome assessment: method not described.
Withdrawals and dropouts: not described.
Jadad score 1.
Participants 90 eligible for inclusion. 31 randomised, 23 completed.
Intervention 1-7.
Intervention 2-8. Control- 8.
Age range given in categories: <30=7, 30-50=14, >50=10.
Mean age: 43.5 years.
Sex: Male 14, female 17.
Asthma diagnosis by physicians using Scadding’s (1976) criteria for clinical and body plethysmographic
examinations.
Severity of asthma: Light (10), medium (9), Severe (12).
Hospital clinic setting (Germany).
Inclusion criteria: Clinic patients with asthma but not had group therapy.
Exclusion criteria: patients who had received group therapy in the past.
Interventions Intervention 1: Exchange of information, discussion sessions and autogenic training (7)
Intervention 2: Exchange of information, discussion sessions and functional relaxation (8)
Control: waiting group offered intervention after one year (8).
40 sessions delivered over 12 months.
Intervention delivered by physicians (’internists and psychosomatics).
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Characteristics of included studies (Continued )
Outcomes Use of bronchodilators; use of steroids; use of inhalation sprays; pulmonary function (resistance and con-
ductance); psychological state and anxiety (MMPI fear index), patients’ observation of their own bodies; GP
visits; hospitalisation (number of days).
Measured at baseline and 12 months.
Notes Comparison between functional relaxation and control only.
Data presented as change scores between groups with no SD.
No sample size calculation.
Allocation concealment B
Study Erskine 1979
Methods RCT (parallel design).
Randomisation method: Patients matched in pairs according to age, sex, FEV1, and severity of asthma, then
randomly allocated to one of the 2 intervention groups. Method of randomisation not described.
Withdrawals and dropouts: 2 patients withdrawn, characteristics not described.
Jadad score 2.
Participants Number eligible not stated. 12 randomised, 10 completed.
Intervention 1- 5.
Intervention 2- 5.
Age: 16-46 years, mean age 30.
Sex: not stated.
Physician diagnosed asthma using ATS criteria.
Severity: Moderate or severe, numbers not stated.
Setting not stated (authors from Australia).
Inclusion criteria: moderate and severe asthma. Exclusion criteria not stated.
Interventions Intervention 1: Muscular and mental relaxation techniques.
Intervention 2: muscular relaxation techniques.
No control group
Intervention given once a week for 4 weeks.
Intervention delivered by ’the therapist’.
Outcomes FEV1, weekly symptom questionnaire (Kinsman et al. 1973), daily symptom questionnaire (locally designed),
subjective severity rating (5 point scale); Self report measurements - psychological, physical and bronchocon-
striction; Post treatment questionnaire: expectations of treatment, success of the treatment, frequency of
relaxation performed at home.
Outcomes measured once a week for 3 weeks pre-treatment, during treatment and 6 weeks after (13 weeks
in total).
Notes No imputable data in this trial. Results are reported as means without standard deviations. FEV1 data is
graphical only.
No sample size calculation.
Allocation concealment B
Study Ewer 1986
Methods RCT (parallel design).
Randomisation method: Not clear in paper but used computerised randomisation tables, allocation concealed
(from correspondence with TE).
Outcome assessment blinded. Withdrawals and dropouts described.
Jadad score: 3.
Participants Number eligible not stated. 44 randomised, 39 completed.
Intervention (low susceptibility to hypnosis)- 10. Intervention (high susceptibility to hypnosis)- 12.
Control (low susceptibility to hypnosis)- 7. Control (high susceptibility to hypnosis)- 10.
Age: 18-45.
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Characteristics of included studies (Continued )
Sex: Male 15, female, 24.
Physician diagnosed asthma.
Severity: mild to moderate, numbers not stated.
Setting: asthma clinic, patients recruited from
the local community (New Zealand).
Inclusion criteria: History of mild to moderate asthma. Exclusion criteria: a reduction of less than 20% in
the ratio of forced expiratory volume in one second to forced vital capacity with the maximum concentration
of methacholine, a history of severe asthma, concurrent systemic steroid treatment, pregnancy, history of
psychosis or relevant medical illness.
Interventions Intervention: Hypnotic induction with progressive relaxation, progression of guided imageries, ego enhance-
ment, self hypnosis. Half hour sessions over six weeks.
Intervention delivered by physician (project leader).
Control: half hour sessions with asthma nurse over 6 weeks.
Outcomes FVC, FEV1, FEV1/FVC (%), PEF, MEF at 50% VC. FRC, RV and airways resistance measured by Collins
Plethysmograph, bronchial responsiveness, subjective sensitivity. Diary recordings of PEF twice daily, daily
use of drugs, symptoms related to asthma (cough, activity limitation, wheeze, phlegm, nocturnal symptoms),
psychological profile using STAI (Spielberger et al 1970), Zung’s self rating depression scale (Zung 1965)
and Pilowsky’s illness behaviour questionnaire (Pilowsky et al 1969).
Outcomes measured before and one week after treatment for lung function, methacholine challenge test,
and psychological profiles.
Notes Psychological profile results reported in another paper (not published).
No sample size calculation.
(author delivered intervention but outcome assessment was blinded).
Allocation concealment A
Study Henry 1993
Methods RCT (parallel design).
Randomisation method: not stated. Outcome assessment method: not stated.
Withdrawals and dropouts: not described.
Jadad score 1.
Participants Number eligible not stated. 24 randomised, Intervention 12, Placebo 12. Dropout rate not stated.
Age: 18-58 years (mean 39.66).
Sex: Male 3, female 21.
Physician diagnosed chronic asthma. Severity: moderate to severe. Numbers not stated.
Setting: Hospital clinic in Spain.
Inclusion criteria: presence of psychopathological disorders or psychosocial factors associated with the asth-
matic disorder requiring treatment as well as imperfect control of asthma with conventional medical treat-
ment; Spirometric evidence of bronchial asthma; age between 18 and 60 years.
Exclusion criteria: severe disorders; mental retardation or other contraindications for autogenic therapy.
Interventions Intervention: Autogenic therapy.
Placebo: supportive group psychotherapy including an educational component.
Intervention and placebo group sessions one hour a week over eight months.
Delivered by ’the therapist’.
Outcomes FVC, FVC % predicted, FEV1, FEV1 % predicted, FEF 25-75, FEF 25-75 % predicted, MEF 50, MEF 50
% predicted.
Measured at pre-treatment and post treatment, exact measurement points not stated.
Psychological outcomes (reported in separate spanish publication): ’reactivity to stress’ measured by ques-
tionnaire with four sub scales vegetative, emotional, cognitive and behavioural (Gonzalez de Rivera, 1983).
Measured before and after treatment (exact time not given).
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Characteristics of included studies (Continued )
Notes Within group differences reported for all lung function outcomes. Between and within group differences
reported for psychological outcomes.
No sample size calculation.
Allocation concealment B
Study Lehrer 1994
Methods RCT (parallel design).
Randomisation method: not stated. Outcome measurement method: described but not stated if blinded.
Withdrawals and dropouts: described.
Jadad score 2.
Participants 153 eligible after telephone screening. 106 randomised after further screening. 72 completed. Intervention
1- 25, Intervention 2- 26, Control- 21.
Age: 18-65 years.
Sex: Male 51, female 55.
Physician confirmed diagnosis of asthma.
Severity: mild to moderate (on average), numbers not stated.
Setting: Not clear but may have been hospital clinic in USA, may have several centres.
Inclusion criteria: Physician diagnosed asthma by history, physical examination, measurement of diffusion
capacity and spirometry; Bronchial hyperreactivity to methacholine challenge test.
Exclusion criteria: Gross psychopathology, psychoactive medications, smokers, pregnant women, prior expo-
sure to any form of relaxation therapy, asthma triggered only by exposure to specific easily avoided allergens,
pulmonary disease other than asthma.
Interventions Intervention 1: Progressive muscle relaxation.
Intervention 2 : listening to relaxing music.
Control (waiting list).
8 sessions with one hour a day at home (of intervention) in between sessions. Length of programme not
given.
Interventions delivered by ’relaxation therapist’.
Outcomes Methacholine challenge test results, FEV1, FVC, Peak flow, FEF50, asthma symptom checklist (Kinsman
et al 1973), relaxation questionnaire (9 point Likert scale), daily medication consumption and symptoms as
reported in a log, Semantic differential rating (Osgood, 1957) of treatment and relationship with relaxation
therapist and respiratory physician.
Outcomes for intervention groups measured at baseline and after each session. Control group had three
measurement points (time not stated).
Notes Lung function outcomes presented graphically.
Sample size calculation done.
Allocation concealment B
Study Lehrer 1997
Methods RCT (parallel design).
Randomisation method: not stated. Outcome measurement method: described but not blinded.
Withdrawals and dropouts: numbers given but not described.
Jadad score: 1.
Participants Number eligible not stated. 17 randomised, 15 completed.
Intervention 1-5, Intervention 2-6, Control-4.
Age: 18-65 years (mean 37.8).
Sex: Males 5, females 12.
Asthma diagnosis by respiratory physician.
Severity: not stated.
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Characteristics of included studies (Continued )
Setting: not clear but may be hospital asthma clinic.
Inclusion criteria: History of recurrent asthma in the prior 12 months, wheeze that responds to B2 aerosol
therapy OR positive methacholine challenge test in the last 12 months OR bronchodilator response on the
laboratory of >= 20% in FEV1; abnormal spirometry (FEV1< 80% or FEF50% < 60%) in prior 12 months.
Exclusion criteria: Chronic bronchitis or sinusitis, emphysema or non-asthma respiratory disease, smoker,
previous experience of a relaxation procedure, cardiovascular or neurological disease, psychiatric disorder
requiring psychoactive medication or which might interfere with understanding of treatment procedures
and/or co-operation with them.
Interventions Intervention 1: Respiratory Sinus Arrythmia Biofeedback. RSA biofeedback given, then instruction given to
increase amplitude of respiratory sinus rhythms. No relaxation or autogenic instructions were used.
Intervention 2: EMG Biofeedback. Instruction given to relax shoulder muscles and breathe automatically.
Electrodes measured thoracic muscle activity. Autogenic and progressive muscle relaxation methods used
with incentive spirometry and EMG feedback.
Control (waiting list): Three testing sessions at two week intervals where participants were told to relax with
eyes open.
6 intervention sessions given at weekly intervals (30 minutes each).
Training and testing done by same person (co-author), Profession not stated.
Outcomes Respiratory impedance (ri); end tidal CO2; thoracic and abdominal breathing; peak respiratory flow; minute
volume; heart “period” (R-R) intervals and amplitude, sensations of relaxation by Relaxation Inventory (Crist
et al, 1989), Asthma symptoms (frequency of symptoms in previous week), Medication consumption
Outcomes measured at one, four and six weeks.
Notes No sample size calculation.
Allocation concealment D
Study Loew 2001
Methods RCT (cross-over).
Method of randomisation: computerised randomisation to two medical institutions and to three treatments.
Outcome measurement: described and blinded.
Withdrawals and dropouts: described.
Jadad score: 3.
Participants Number eligible not stated.
21 adults randomised, 16 completed.
Intervention 1 (eFR): 18, Intervention 2 (IT): 19, Placebo (PRT): 21.
Age: 23-74 years (mean 48.9).
Sex: Males 7, females 14.
Asthma diagnosed by history of asthma with current manifestation of reversible reduction in airway resistance.
Severity: not stated.
Setting: Outpatients clinic at two medical institutions in Germany.
Inclusion criteria: History of asthma with current reversible reduction in airways resistance; no oral corticos-
teroids for duration of trial.
Exclusion criteria: acute dyspnoea, sputum production, fever, chronic bronchitis, no bronchoconstriction on
a treatment day (this meant patient was withdrawn from study).
Interventions Intervention 1: Functional relaxation (eFR). Instruction given while patient sitting in the cabin of the body
plethysmograph. The patients then practiced these instruction while measurements were taken. Intervention
2: Inhaled terbutaline (IT). 1x0.5mg dose of terbutaline given. Pulmonary function tests were carried out
after 5 minutes.
Placebo relaxation technique (PRT).
Based on isotonic exercises of one hand in conditions comparable to the eFR intervention.
Instructions given for minutes. All three therapies received in course of 3 consecutive days.
Training delivered by trained therapist, same therapist supervised administration of terbutaline.
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No analysis for carry over effects.
Outcomes Airways resistance (Raw); specific airways resistance (sRaw), FEV1, PEF, MEF 50, MEF 75.
Outcomes measured before and after each therapy.
Responder analysis also done. Responders defined as achieving a decrease of at least 20% in sRaw and increase
in FEV1.
Notes No sample size calculation. Each person had each intervention on different days except 2 missed IT and 3
missed eFR as they had no bronchoconstriction that day.
Allocation concealment B
Study Mussell 1988
Methods RCT (cross-over).
Method of randomisation: not described.
Outcome assessment: described, but confusing as not stated who performed assessments- study described as
double blind.
Withdrawals and dropouts: not described.
Jadad score: 2.
Participants Number eligible not stated. 16 adults randomised to exercise challenge or hyperventilation challenge, then
half of each group randomised to biofeedback training. Dropout rate not stated. Age: 22-44 years.
Sex: Males 11, females 5.
Asthma diagnosis confirmed by a testing if FEV1 would fall by at least 20% following a standardised
hyperventilation challenge.
Severity: not stated. Setting: not stated, ? Chest clinic in UK.
Inclusion criteria:
A fall in FEV1 of at least 20% after a standardised hyperventilation challenge. All subjects refrained from
using their anti-asthma medication for at least 12 hours before visiting the laboratory.
Exclusion criteria: History of cardiopulmonary disorders other than asthma.
Interventions After randomisation into two groups of 8 for exercise or hyperventilation challenge tests, half of each of these
two groups were randomly assigned to biofeedback training or control. The others were untrained. Subjects
then given 5 randomly ordered interventions- 1) active bronchodilator 2) placebo bronchodilator 3) correct
biofeedback (using tracheal noise and feedback on FEV1 changes) 4) wrong biofeedback (wrong information
is fed back to the subject) 5) no treatment.
A second challenge test was administered 40 minutes after the first challenge to observe for refractory effects.
All interventions (or control) were given double blind over 5 visits. Length of study not stated.
Person delivering interventions not stated.
No analysis for carry over effects.
Outcomes FEV1 measured at baseline, 1,4, and 8 minutes after the challenge, then at 2 minutes and every 5 minutes
after treatment (given at 10 minutes) until lung function back to within 10% of baseline values. Eysenck
personality inventory: extraversion and neuroticism sub scales measured after the final test session in order
to correlate personality type with recovery rates.
Notes No sample size calculation.
All FEV1 data presented graphically.
Allocation concealment A
Study Payette 1977
Methods RCT (parallel design).
Method of randomisation: not stated. Outcome assessment described but not blinded. Withdrawals and
dropouts not described.
Jadad score 1.
Participants Number eligible not stated. 18 adults randomised.
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Intervention: 11, Control: 7
Dropout rate not stated.
Age: 22-67 years.
Sex: 5 males, 13 females.
Asthma diagnosis by medical diagnosis.
Severity of asthma not stated.
Setting: Asthma and allergy outpatient clinic at Tucson Medical Center, Arizona, USA.
Inclusion criteria: Primary medical diagnosis of asthma, in adequate health to complete the study, over age
of 18, patient of the asthma clinic.
Interventions Intervention:EMG biofeedback training-surface electrodes applied to lower frontalis muscle, subjects told
to relax using biofeedback auditory and visual signals from frontalis muscle area. Told by lowering tone and
microvolt setting they were relaxing.
Control: Instructions to relax as best they could while reclining in comfortable recliner chair.
12 treatment sessions given over 20 minutes.
Length of study not stated.
Intervention given by investigator.
Outcomes Blood pressure; Pulmonary function tests- FVC, FEV1, %FEV1/FVC; Schedule of Recent Experiences
(SRE); Taylor-Johnson Temperament Analysis (Taylor et al 1974).
Outcomes measured at baseline. Blood pressure and pulmonary function tests measured before and after each
session. At 2 post-baseline sessions after the treatment sessions the SRE and The Taylor-Johnson Temperament
Analysis were administered. All outcomes were also measured at 30 days following the last session.
Notes No sample size calculation.
Results presented graphically and by statistical tables, mean scores not presented.
Allocation concealment D
Study Put 2003
Methods RCT (parallel design).
Method of randomisation: drawing of envelopes.
Outcome assessment: performed by independent researchers unaware of treatment allocation.
Withdrawals and dropouts: described.
Jadad score 4
Participants Number eligible 101. 25 adults randomised with one drop out from each group.
Intervention: 12.
Waiting list control: 11.
Age: mean 43 years in intervention
group, mean 48 years in control group.
Sex: males 11, females 12.
Asthma diagnosis by ATS criteria at least 6 months earlier.
Severity: Mild 7, Moderate 15, Severe 1.
Setting: University hospital outpatient pulmonary clinic, Belgium.
Inclusion criteria: Asthma diagnosis using ATS criteria at least 6 months earlier. Experience of asthma
complaints and impairment despite adequate medical treatment.
Exclusion criteria: Aged less than 18 or over 65 years, occupational asthma, nicotine, drug or alcohol abuse,
absence of asthma symptoms during the last 6 months, brittle asthma, previous participation in an educational
or other asthma programme.
Interventions Intervention: Psycho-educational programme where the patients’ personal illness representations, or their
cognitions regarding origin, symptoms, course and therapy of their illness were identified. Information about
the pathophysiology of asthma, mechanisms of medication, eliciting factors etc. was provided in an interactive
way. Behavioural techniques such as self-monitoring/self observation, stimulus control, and response control
were also taught. Certain parts of the programme were elaborated upon according to individual need.
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Control: waiting list.
Programme delivered by two independent researchers. Profession not stated. Delivered over 3 months in 6
one hour individual sessions.
Outcomes Health related limitations in quality of life during the past 2 weeks assessed by McMaster Asthma Quality of
Life Questionnaire (Juniper et al, 1992), Subjective symptomatology of asthma measured by Asthma Symp-
tom checklist (Kinsman et al 1973), Negative affectivity as a personality trait including negative emotional
conditions (irritability, nervousness, emotional instability was measured by Negative Emotionality Scale (Tel-
legen et al, 1988). Frequency of non-adherent behavior was measured by The Adherent Scale (Brooks et al,
1994). Patients’ knowledge regarding asthma, attitude towards the illness, and self-efficacy regarding per-
ceived ability to control the disorder was measured by The Knowledge, Attitude, and Self -efficacy Asthma
Questionnaire (KASE-AQ) (Wigal et al, 1993). Outcome measurement was done at baseline, 3 months
and 6 months for the control group; baseline, immediately after the treatment interventions and 3 months
later for the intervention group. Assessment done by researchers blind to the treatment allocation. PEF was
measured by the subjects at home twice daily during 14 consecutive days.
Notes No sample size calculation. Randomisation method is unclear, states done by sealed envelopes but no de-
scription of method is given. Between group analysis done by repeated measures analysis of variance.
Allocation concealment B
Study Sommaruga 1995
Methods RCT (parallel design).
Method of randomisation: Not clear in paper but used computerised randomisation tables (from correspon-
dence with MS).
Outcome measurement: described but not stated as blinded.
Withdrawals and dropouts: not described.
Jadad score: 2.
Participants Number eligible not stated. 40 randomised, 36 completed. Intervention- 20, control-16.
Age: mean 48.0 range not reported.
Sex: Males 21, females 19.
Asthma diagnosis according to ATS criteria (1987).
Severity: not stated, all using drug therapy.
In-patients with asthma.
Setting: Hospital Respiratory Department in Italy (inpatients).
Inclusion criteria:
Asthma diagnosed according to ATS guidelines.
Exclusion criteria not stated.
Interventions Intervention: Asthma Rehabilitation group involving education and cognitive behavioural intervention with
medical treatment following international guidelines. Control: Medical treatment following international
guidelines.
Education programme was delivered by physician, physiotherapist and psychologist twice during admission
and quarterly for 12 months. Cognitive behavioural intervention delivered by psychologist during 3 individual
meetings.
Outcomes Trait anxiety measured by STAI (Spielberger et al. 1970); Depression, assessed by QD questionnaire; Psy-
chophysiological disorders, assessed by QPF from Cognitive behavioural assessment questionnaire (Sanavio
et al. 1986); emotional reactions to asthmatic crises, assessed by Asthma Symptom Checklist (Kinsman et al.
1973) in Italian version; Optimism, negative staff regard, specific internal awareness, external control psy-
chological stigma, authoritarian attitude, assessed by Respiratory Illness Opinion Survey (Staudenmayer et
al. 1978); Internal beliefs, external powerful others and external chance assessed by Health Locus of Control
Scale (Wallston et al. 1976) (Italian Version).
Outcomes measured at baseline and at one year.
Notes No sample size calculation, Within group analysis only.
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Allocation concealment B
Study Wagaman 2000
Methods RCT (parallel design).
Method of randomisation: Following hypnotic susceptibility and psychometric testing, participants were
stratified according to hypnotic susceptibility (large representation (46%) of highly hypnotisable subjects).
Randomised to three groups. Randomisation method not described.
Outcome assessment: Assessments and medical examinations blinded, but investigator performed interven-
tions and delivered psychometric assessments.
Withdrawals and dropouts: 9 withdrawals, no description given.
Jadad score: 2.
Participants Number eligible: 90. 45 met inclusion criteria after interview.
30 adults randomised, 21 completed.
Intervention 1: hypnotic control group- symptom control (7), Intervention 2: Hypnotic suggestion group-
immune function and airway relaxation (7), Placebo control (7).
Age: 19-65 years (mean 41.0)
Sex: Males 3, Females 18.
Asthma diagnosed by physicians.
Severity of asthma: Moderate to moderately severe- classified using National Institute of Health Guidelines.
Setting: Allergy and Immunology private practice.
Inclusion criteria: Full time local residents, non-smokers at present, inexperience with hypnosis and other
similar techniques, not receiving immunotherapy.
Exclusion criteria: History of past or present psychiatric disorders, past or present psychotropic drug use,
significant secondary gain, significant psychosocial problems, recent major loss (death, job, divorce).
Interventions Intervention 1: Hypnotic control group with taped hypnotic sessions directed at symptom relief through
ability to relax smooth airway muscle. Intervention 2: Hypnotic suggestion group, taped hypnotic sessions
directed at improvement of immune function, resolution of inflammation and biochemical relief of bron-
chospasm.
Control: Non hypnotic placebo group, taped session of neurophonic tones- told may or may not contain
subliminal suggestions pertaining to asthma care and control.
6 sessions for each group delivered by hypnosis therapist (author), 3 one week apart, 3 reinforcement sessions
delivered at 3 month intervals. Tapes used by participants daily and for symptom relief.
Outcomes Daily patient diaries of PEF, asthma symptom score, frequency of use of PRN medication, work/school
absences, private doctor visits, emergency room visits, and hospitalisations. Recorded for 3 to 4 months
before sessions commenced and for one year afterwards.
Initial and final interview done.
Clinical assessments done every 3 months by physicians blind to group allocation- FEV1, FEF 25-75%, PEF.
Psychometric testing done by author at baseline and one year follow up. Eysenck Personality Inventory to
measure neuroticism, extraversion, and lying. Marlowe-Crowne Social Desirability Scale (Crowne & Marlowe
1960) to measure repressive coping. STAI (Spielberger et al. 1970) to measure anxiety. Self-control schedule
(Rosenbaum 1980) to measure the solution of behavioural problems. Dysfunctional Cognition Inventory
(Zocco 1984)- catastrophizing scale, Asthma Symptom Checklist (Kinsman et al. 1973).
Notes No sample size calculation.
Data presented in graphical form.
Mainly within group analysis.
Allocation concealment C
Abbreviations-
ATS American Thoracic Society, EMG- Electro-myogram, FEF- Forced expiratory flow, FEV1- Forced expiratory volume over one
second, FEV1/FVC- ratio of FEV1 and FVC, FRC- Functional residual capacity, FVC- Forced vital capacity, MEF- Mid expiratory
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flow, PEF- Peak expiratory flow, RCT- Randomised controlled trial, RV- Residual volume, SD- Standard Deviation, STAI- State-Trait
Anxiety Inventory, VC- Vital capacity.
Characteristics of excluded studies
Ago 1976 CCT of teaching patients about the mind-body relationship
Allen 1995 RCT of a self-management programme
Anon 1968 RCT of hypnosis in adults and children. Unable to separate data
Bailey 1990 RCT of a self-management programme. Intervention was mainly education with a small element of counseling
Barendregt 1957 CCT of Group psychotherapy
Ben-Zvi 1982 Before and after study of hypnosis
Boulet 1995 CCT of an education only programme
Cambach 1997 RCT of pulmonary rehabilitation including asthma and chronic obstructive pulmonary disease (COPD) patients
Ciurluini 1993 CCT of psychotherapy techniques
Clark 1997 Review of self-management education programmes
Coen 1996 RCT of relaxation. Study includes adults and children. Unable to separate data
Conte 1981 Review of psychotherapy for medically ill patients
Cox 1991 CCT of rehabiltation. Study includes asthma and COPD patients. Unable to separate data
Deter 1983a Cost effectiveness study based on data of included study (Deter 1983)
Devine 1996 Meta-analysis of psychoeducational care
Erskine-Milliss 1987 Two studies of biofeedback in adults and children (before and after study)
Franco 1982 CCT of hypnosis
Fujii 1997 Case study of step-down management of asthma
Ghosh 1998 RCT of self-management without psychotherapy in adults and children
Groen 1960 Clinical study, not controlled or randomised
Grover 2002 CCT of Cognitive Behavioural Therapy
Hackman 2000 Review of hypnosis in adults and children with asthma
Haire-Joshu 1993 Survey, focus groups and interview to assess patients’ attitudes according to clinical setting
Hajjar 1999 Review of behavioural interventions in asthma
Harding 1982 CCT Of biofeedback training
Hashizume 1996 Psychosomatic therapies in a before and after study
Hirokawa 1992 CCT of biofeedback apparatus
Huntley 2002 Review of relaxation therapies for asthma
Jonckheere 1997 Review of psychosomatic issues in a range of diseases
Kang 1993 Before and after study of the impact of psychological factors in adolescents.
Kaptein 1987 Review (COPD)
Kern-Buell 2000 Adults and children included in RCT on relaxation
Khateeb 1995 Meta-analysis of psychotherapy
Klingelhofer 1988 Review of asthma self-management programmes
Kolbe 1996 Knowledge of self-management outcome measure validity study
Kotses 1991 CCT of self-management without psychotherapy
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Kotses 1995 RCT of self-management without psychotherapy
Kotses 1996 RCT of self-management, primarily education although some received a relaxation tape
Lahdensuo 1996 RCT of a self-management programme
Laidlaw 1994 Before and after study of hypnosis
Lehrer 1986 CCT of relaxation and biofeedback
Lehrer 1992 Review of psychological approaches in asthma
Lehrer 1993 Review of the relationship between emotion and asthma
Lehrer 1997a Analysis of data from 1994 study (included) to study the physiological relationship between pulmonary function
and autonomic control of the heart.
Levendel 1980 Narrative review of the biofeedback method
Lewith 1996 Review of complementary therapies in asthma
Linden 1994 Review of autogenic training in a range of diseases
Loew 1996 Before and after study of functional relaxation
Maes 1988 CCT of an education and behaviour modification intervention
Matts 1973 Review of the treatment of bronchospasm (including psychological)
Moore 1965 CCT of behavioural therapy. Adults and children included in study
Murphy 1989 CCT of hypnotic susceptibility and relaxation
Nagata 1995 Before and after study of a psychosomatic treatment
Negley-Parker 1986 Case report of hypnotherapy of families of children with chronic ilness
Peper 1992 CCT of behavioural and desensitization programme using biofeedback
Richter 1982 Review of psychosomatic aspects of asthma
Richter 1987 Review of behavioural therapy and relaxation
Ringsberg 1990 RCT of self-management without psychotherapy
Ritz 2001 Systematic review of relaxation therapies for asthma
Sachs 1993 CCT of relaxation training
Sauer 1978 CCT of autogenic training
Schaeffer 1975 CCT of self-training
Sclare 1957 CCT of group therapy
Snyder 1987 RCT of self-management without psychotherapy
Spiess 1988 RCT of education intervention (non-randomised sub group received relaxation therapy)
Stepans 2000 RCT of patients with asthma and COPD. Unable to separate data.
Steptoe 1981 CCT of biofeedback, non asthmatic volunteers included
Stout 1997 RCT of breathing retraining only
Stuhr 1996 Review of psychosomatic and psychotherapy research
Vedanthan 1998 Yoga RCT
Vickers 1997 Survey and review of complementary therapies
Wilson 1975 Cross-over study of transcendental meditation
Wilson 1993 RCT of self-management without psychotherapy
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Characteristics of ongoing studies
Study Harrison
Trial name or title The Coping with Asthma Study: A randomised controlled trial and
economic evaluation of a home-based coping skills training programme for
high risk asthma sufferers.
Participants 92 patients aged 15-66 (mean 36.46) recruited mainly from 5 hospital
respiratory departments in Norfolk and Suffolk with a small number recruited
from general practice. The setting for the study is the community (patient’s
homes) with the intervention co-ordinated via the lead hospital. Patients
are recruited on the basis that they have severe asthma as indicated by them
being on British Thoracic Society Step 4/5 treatment and/or having had
previous admissions for asthma. The patients are also deemed to be at risk
of future adverse asthma outcomes due to failure to attend clinic
appointments or comply with their asthma management in other ways (e.g.
non-compliance with medication or changes in medication, failure to keep
peak flow records when asked)
Interventions Four fortnightly home visits of approximately
one hour in length conducted by an asthma nurse for two months, supplemented
by phone calls between visits and monthly for four months after the last
visit, making a 6 month intervention in total. Patients are also able to
phone the asthma nurse throughout and after the duration of the
intervention. The nurse provides asthma education, self-management and
coping skills training and, with clinical supervision from a general
practitioner with psychiatric training and Health Psychologist, aims to
address co-existing psychosocial problems which compromise effective asthma
management. The intervention takes a cognitive behavioural approach and
involves liaison with/referral to other medical, psychological or social
services as necessary.
The control group continues with routine care comprising usual use of
primary, secondary and emergency health services which varies to some degree
across the hospitals involved.
Outcomes Primary outcome: Asthma control assessed via a score from a brief
questionnaire asking about asthma symptoms in the past month (questionnaire
based on recommendations from Royal College of Physicians Asthma Outcomes
seminar 1999, used in previous local studies, reliability and validity work
being undertaken).
Secondary outcomes: Quality of life assessed via the Living with Asthma
Questionnaire (Hyland) and Short Form 36 (Ware et al).
Economic evaluation will also involve assessment of direct health care,
social service and patient costs and indirect costs.
Additional/explanatory outcomes: Psychiatric morbidity assessed via the
General Health Questionnaire 12 and Hospital Anxiety & Depression Scale,
attack and everyday coping assessed via the Asthma Coping Questionnaire
(Maes & Schlosser), perceived control assesed via the Perceived Control of
Asthma Questionnaire (Katz et al), attack management and compliance assessed
via 2 subscales of the Revised Asthma Problem Behavior Checklist (Creer et
al) and compliance scale of Moriskey, readiness to change asthma self
management behavour assessed via an Asthma Stage of Change Questionnaire
developed for the study and supplemented with additional questions on
performance of self management behaviours (trigger avoidance, peak flow
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monitoring, smoking, exercise etc.)
Outcomes are assessed via self administered questionnaires completed by
patients during interviews in their home conducted at baseline and 2, 6 and
12 months after entry into the study. The primary endpoint is 6 months (the
end of the intervention for those receiving the nurse programme).
Starting date September 1999
Contact information Study researcher: Jane Smith, School of Medicine, Health Policy & Practice,
University of East Anglia, Norwich, NR4 7TJ, UK. Email: j.r.smith@
uea.ac.uk, Phone: 01603 593584
Principal investigator: Dr Brian Harrison, Department of Respiratory
Medicine, Norfolk & Norwich University Hospital NHS Trust, Colney Lane,
Norwich, NR4 7UY, UK. Email: brian.harrison@norfolk-norwich.thenhs.com,
Phone: 01603 289642.
Notes Expected completion early 2003
Funded by the British Lung Foundation with sponsorship from the Community
Fund (formerly National Lottery Charities Board)
A D D I T I O N A L T A B L E S
Table 01. Description of Psychotherapeutic Techniques
Technique Description
Behavioural therapies Concerned with identifying the processes by which behaviour has been learned via association, reward
or observation and modifying behaviour using methods such as systematic desensitization, selective
reinforcement and positive modelling. The behaviour itself, rather than underlying motivations, is the
focus of behavioural interventions.
Cognitive therapies Identification and constructive management of damaging thoughts, such as perceptions of helplessness
or inappropriate fear of asthma attack that can trigger episodes. Information (e.g. about the relationship
between anxiety and bronchoconstriction) also targets cognitions.
Cognitive behaviour therapy Using behavioural techniques to change negative thoughts mediating health behaviour. In asthma
may address incorrect symptom attributions (over- or under-playing their significance) giving rise to
suboptimal medication use, or may use systematic relaxation techniques to extinguish fear responses
associated with psychosocial triggers.
Relaxation techniques Designed to control stress & anxiety. In asthma, may reduce panic or fear & improve breathing and
respiratory function. Approaches include progressive relaxation (systematically creating tension and
release in different parts of the body and/or via guided mental imagery), autogenic training (focuses on
attending to bodily feelings and mentally controlling them), hypnotherapy (deep relaxation that may
be induced using mental imagery, often accompanied by autosuggestion to create positive thoughts &
feelings), and biofeedback (feedback of biological indicators, such as tracheal noise, which the subject
must control via relaxation. May also be considered a behavioural intervention since the feedback can
act as a reinforcer).
This review has no graphs.
I N D E X T E R M S
Medical Subject Headings (MeSH)
Adult; Asthma [psychology]; Health Services Needs and Demand [utilization]; Psychotherapy; Randomized Controlled Trials
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